Nigel Thompson is a Senior Advisor at DGA-Albright Stonebridge group, a founding member of DGA Group, and is based in New York City. With 30 years of experience in international pharmaceutical markets, he helps clients navigate the global regulatory environment, specializing in economic strategy, pricing, reimbursement, government relations and business development. 

Mr. Thompson also currently serves as the President of Parks Pharma Consulting. Previously, he was the Executive Director of Economic and Development Strategy at Merck, where he developed strategies to enhance market access in Europe and emerging markets. He also served as the Pharmaceutical Advisor to the World Bank, facilitating dialogue between pharmaceutical companies and the organization on issues in emerging markets.

Mr. Thompson is also a British Chartered Accountant. He is fluent in French.